Linscott Walt Addison
SEC CIK 1648585 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | Chief Business Off | 54.4K | $393 | — | 2 | 2022-09-07 | 2025-12-22 |
Most active insiders at INDP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ben-Tzvi Avraham | Dir | — | — |
| 2 | Newman Michael James | CSO, Dir | — | — |
| 3 | Sassi Nir | CFO | — | — |
| 4 | Linscott Walt Addison | COO | — | — |
| 5 | Meckler Jeffrey A | Co-CEO, Dir, 10% | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-22 | INDP | Indaptus Therapeutics, Inc. | Linscott Walt Addison | COO | A - Grant | $2.03 | +54.4K | 54.4K | +1,088,420% | +$110.5K | |
| 2022-09-09 | 2022-09-07 | INDP | Indaptus Therapeutics, Inc. | Linscott Walt Addison | Chief Business Off | P - Purchase | $2.62 | +150 | 150 | New | +$393 |
Purchase Sale Sale after option exercise All abbreviations